Atlas Trials

PS-341 in Combination With Herceptin in Advanced Breast Cancer That Overexpresses HER-2

Clinical trial NCT00199212 · COMPLETED

Trial details

NCT number
NCT00199212
Sponsor
Jules Bordet Institute
Status
COMPLETED
Phase
Phase 1
Study type
INTERVENTIONAL
Carcinoma Breast Stage IV
Start date
2003-10-01
Primary completion
2007-12-01
Enrollment
19

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.